trending Market Intelligence /marketintelligence/en/news-insights/trending/o9keoxk79nabukgylcdn0a2 content esgSubNav
In This List

Oncobiologics CEO steps down; interim replacement named

Blog

Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share


Oncobiologics CEO steps down; interim replacement named

Oncobiologics Inc. said its founder Pankaj Mohan stepped down from the positions of chairman and CEO, effective June 18.

The Cranbury, N.J.-based biopharmaceutical company said Mohan will remain a board member and will enter into a consulting agreement to provide advisory services in connection with the development of its product candidate ONS-5010.

Oncobiologics said board member Randy Thurman will assume the role of executive chairman and CFO Lawrence Kenyon will serve as interim CEO.

Thurman joined Oncobiologics' board in April, while Kenyon joined the company as CFO and corporate secretary in September 2015.

Oncobiologics' board has formed a search committee to find a permanent CEO.